OSE Immunotherapeutics Announces Licensing Deal for Neoepitope Combination Tedopi® in Korea with Chong Kun Dang Pharmaceutical Corporation

    NEXT STORY
    Angion Presents Positive Long-term Data from Phase 2 Clinical Trial of ANG-3777 in Delayed Graft Function at the American Society of Nephrology Kidney Week 2019
    PREV STORY
    Eloxx Pharmaceuticals Presents New Positive Data for ELX-02 at the American Society of Nephrology (ASN) Kidney Week 2019
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Precision Therapeutics Reports Year End 2018 Financial Results and Provides Corporate Update

    author_avatar
    NASDAQ Market News

    Atara Bio to Participate in the Morgan Stanley Global Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., Sept. 08, 2016 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), ...

    author_avatar
    NASDAQ Market News

    Nufactor® Selected by Octapharma® as One of the Limited Distribution (LD) Pharmacies for Cutaquig®

    author_avatar
    NASDAQ Market News